Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
AdvisorShares Psychedelics ETF
(NY:
PSIL
)
18.61
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
42
Open
18.61
Bid (Size)
6.810 (100)
Ask (Size)
18.59 (100)
Prev. Close
18.61
Today's Range
18.61 - 18.61
52wk Range
9.580 - 21.61
Shares Outstanding
7,499
Dividend Yield
0.43%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order
↗
December 19, 2025
Jefferies sees restrictions around non-recreational psychedelics eventually loosen up.
Via
Stocktwits
Topics
Cannabis
ETFs
Government
Why Did KTTA Stock Soar A Whopping 48% Today?
↗
November 28, 2025
The company announced the pricing of a public offering of 80 million shares of its common stock and said that the offering will extend its cash runway through at least the first half of 2028.
Via
Stocktwits
Performance
YTD
+53.5%
+53.5%
1 Month
+7.6%
+7.6%
3 Month
+5.9%
+5.9%
6 Month
+38.7%
+38.7%
1 Year
+78.7%
+78.7%
More News
Read More
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition
↗
November 11, 2025
Via
Stocktwits
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
↗
August 05, 2025
Via
Benzinga
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts
↗
June 23, 2025
Via
Stocktwits
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
↗
May 24, 2025
Via
Benzinga
Topics
Government
5 ETFs That Beat Market Turmoil With Gains Last Week
↗
February 10, 2025
Via
Benzinga
Topics
ETFs
Economy
High-Momentum ETFs Leading the Market This Year
February 07, 2025
Via
MarketBeat
Topics
ETFs
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
↗
January 29, 2025
Via
Stocktwits
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish
↗
January 28, 2025
Via
Stocktwits
5 Best-Performing Sector ETFs Of Q4
↗
January 02, 2025
Via
Talk Markets
Topics
ETFs
Why Is Penny Stock Clearmind Gaining Today?
↗
December 24, 2024
Via
Benzinga
5 Best-Performing Sector ETFs Midway In Q4
↗
November 16, 2024
Via
Talk Markets
Topics
ETFs
Top And Flop ETFs Of The First Half
↗
June 29, 2024
Via
Talk Markets
Topics
ETFs
Best And Worst ETF Zones Of Q2
↗
June 26, 2024
Via
Talk Markets
Topics
Artificial Intelligence
ETFs
Economy
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
↗
June 05, 2024
Via
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
↗
April 17, 2024
Via
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
↗
March 29, 2024
Via
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
↗
March 20, 2024
Via
Benzinga
Topics
Economy
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
↗
March 04, 2024
Via
Benzinga
Mental Health Mavericks: 3 Stocks Changing the Game
↗
February 21, 2024
Via
InvestorPlace
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
↗
February 15, 2024
Via
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
↗
January 27, 2024
Via
Benzinga
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
↗
January 12, 2024
Via
Benzinga
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
↗
January 07, 2024
Via
Benzinga
Frequently Asked Questions
Is AdvisorShares Psychedelics ETF publicly traded?
Yes, AdvisorShares Psychedelics ETF is publicly traded.
What exchange does AdvisorShares Psychedelics ETF trade on?
AdvisorShares Psychedelics ETF trades on the New York Stock Exchange
What is the ticker symbol for AdvisorShares Psychedelics ETF?
The ticker symbol for AdvisorShares Psychedelics ETF is PSIL on the New York Stock Exchange
What is the current price of AdvisorShares Psychedelics ETF?
The current price of AdvisorShares Psychedelics ETF is 18.61
When was AdvisorShares Psychedelics ETF last traded?
The last trade of AdvisorShares Psychedelics ETF was at 12/19/25 08:00 PM ET
What is the market capitalization of AdvisorShares Psychedelics ETF?
The market capitalization of AdvisorShares Psychedelics ETF is 139.56K
How many shares of AdvisorShares Psychedelics ETF are outstanding?
AdvisorShares Psychedelics ETF has 140K shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.